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Tillett and Garner (1) first reported the production by streptococci of a fibrinolytic 
substance capable of lysing a normal human plasma clot. Milstone (2) and Christenseu 
(3) demonstrated that a  proeuzyme, plasminogen, present in the euglobulin fraction 
of  human  blood,  is  essential  for  this  process.  Christensen  (3)  suggested  that 
plasminogen is present in serum as an inactive proteolytic enzyme and is activated 
by a kinase, streptococcal fibrinolysin (streptokinase), to an active proteolytic enzyme, 
plasmin. The latter is able to lyse fibrin clots or other proteins such as casein or gelatin. 
It has been shown  to have a  proteolytic activity similar to,  but not identical with, 
trypsin  (4,  5).  More  recent  reports  (6,  7)  suggest  that  streptokinase  does  not  act 
directly  upon plasminogen,  but  instead  acts stoichiometrically  with  a  proactivator 
to form activator which in turn catalyzes plasminogen to plasmin. 
Streptokinase production is characteristic of the great majority of Group A strepto- 
coccal strains, some strains of human C and G, and a few strains of B  and F  (8). Its 
relation to virulence has been investigated largely through attempts to correlate the 
production in vitro of streptokiuase with the disease source and virulence of a particular 
strain.  Several investigators (9-12) have reported a definite relationship between the 
capacity  of a  strain  to  attack human  fibrin and  its pathogenicity.  More recently, 
efforts to confirm this relationship  have not  been successful  (8,  13,  14). 
Despite  many  investigations  concerning  the  streptokinase-plasminogen 
system,  little  evidence  is  available  dealing  directly  with  streptokinase  as  a 
factor  affecting  the  pathogenicity  of  streptococci.  Accordingly,  the  present 
investigation  was undertaken  to determine  the influence  of the streptokinase- 
plasminogen system on the pathogenicity of streptococci for mice. Since mouse 
plasma  contains  a  relatively small  amount  of plasminogen,  human  plasma  or 
human plasminogen was added as a  source of this substance.  The experimental 
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plan consisted of suspending streptococci and other organisms in saline, strep- 
tokinase, human plasma (or plasminogen), and a  combination of the last two 
substances, and comparing the ability of these suspensions to cause deaths in 
mice. 
Materials and Methods 
Bacterial Strains.wThe following organisms were obtained from the Department of Bac- 
teriology, Medical General Laboratory  (406),  Japan, and maintained in Dffco  brain-heart 
infusion (BHI) broth: Group A streptococcal strains Types 4, 28, 25, and No. 10 (untyped), 
a  Group D streptococcus,  a  Group G  streptococcus, Micrococcus pyogenes var.  a/bus,  and 
Salmonella paratyphi  A. Group A streptococcus No. 95 was obtained from  the Diagnostic 
Laboratory of the Massachusetts Department of Public Health, Boston. 
All strains were passed through mice repeatedly to enhance their virulence; streptococcal 
colonies on blood agar were of the matt type and exhibited good zones of beta  hemolysis 
after  24  hours'  incubation. The  staphylococcal strain was  non-hemolytic and  coagulase- 
positive, Fibrinolysin  tests demonstrated that all of the Group A strains brought about com- 
plete lysis of the six samples of plasma tested within a 6 hour period and usually within 4 
hours. Individual tests were very consistent. The Group G  streptococcus appeared to lag 
behind the Group A strains, but lysis was effected in all cases after overnight incubation. 
The Group D  strain, with few exceptions,  did not elaborate sufficient  SK to promote clot 
lysis. Partial or complete lysis with this strain was occasionally observed, however, with two 
of the six specimens of plasma. Staphylococci generally failed to bring about clot dissolution, 
but in a few instances partial lysis, never complete,  was observed, Results with S. paralyphi 
were variable. In comparison to the Group A strains plasma clots were lysed at a slower rate 
and to a lesser degree by this organism. One specimen of plasma (No.  1456) appeared to be 
completely resistant to lysis by S. paratyphi. 
Streptoklnase (SK).--Varidase, a lyophilizod mixture of at least 100,000 units SK and at 
least 25,000 units streptodornase (SD) per vial, was kindly furnished by Dr. J. M. Ruegsegger 
of the Lederle Laboratories Division, American Cyanamid Company, Pearl River, New York. 
In most cases the dry product was resuspended in 10 mi. saline to give a  concentration of 
10,000 units SK and 2,500 units SD pet ml. It was necessary to employ a combination  of these 
two enzymes because of the non-availability of SK without SD, although SD can be obtained 
without SK. During the course of this work Dr. Ruegsegger  generously supplied two vials of 
"pure" SK. Highly concentrated SD was available and used in a concentration in excess  of 
that in varidase. Preliminary  experiments demonstrated that SD exerted no effect on strepto- 
coccal virulence. Also, experiments with the limited amount of "pure SK" available showed 
results with this substance to parallel results with varidase. Therefore,  SK was regarded as 
the significant  factor in varidase in this study. Numerous other investigators  (15-17)  have 
employed vafidase as a source of SK. 
Mice.--White mice of the SMK strain (Japan),  15 to 18 gin. in weight, were used in all but 
one experiment (Experiment 7, Table I--Carworth Farms strain No. I  mice). Animals were 
maintained on laboratory chow and water ad libitum. 
Blood PToducts.--Warner-Chilcott  diagnostic plasma was used in one experiment (No.  7, 
Table I). In all other cases  blood plasma and serum were  obtained from six donors at the 
blood bank of the Medical General Laboratory (405) and frozen in small amounts until used. 
Plasminogen (PG)  was precipitated from its inhibitors in the euglobulin fraction by acetic 
acid (18) and suspended in a volume of borate-saline buffer equal to that of the serum used 
as the source. In some cases the volume of buffer was adjusted to provide a desired concen- 
tratinn of PG. In such cases the concentration is indicated in the text. Each lot of PG was R.  I.  KRASNER AND  G.  YOUNG  247 
tested for activity by its ability in the presence of SK to promote the lysis of rabbit plasma 
clots. Human blood products were used in all experiments unless otherwise noted. 
Fibrinolysin Test.--The original method of Tillett and Garner (1) was followed with slight 
modification. In serological tubes  0.2  mi. of oxalated plasma was  diluted  with 0.6 ml. of 
physiological saline. 0.5 mi. of the broth culture or SK and 0.45 ml. of a 0.25 per cent solution 
of calcium chloride were added.  Tubes were placed in a 37.5°C. water bath and examined at 
intervals through a 24 hour period noting the time of coagulation and dissolution. 
Standardization of Bacterial Suspcns/oz~.--Cells of 20 to 24 hour cultures in BHI broth 
were standardized in saline at 17 per cent transmission on a Coleman universal spectrophotom- 
eter and centrifuged; 5 ml. of the 17 per cent suspension was centrifuged and resuspended in 1 
ml. of saline. For Salmonella and the Group D  streptococcus it was necessary to standardize 
at 10 per cent transmission and reconcentrate 10 ml. to 1 ml. Dilutions were made from the 
standardized suspension in accordance with the virulence of the organisms. A density of 17 
per cent transmission corresponded in the MacFarland series to tube 3 and contained 9 ×  l0  s 
organisms per ml., whereas 10 per cent transmission corresponded to tube 4 and contained 
12 X  108 organisms per mL 
Testing Influence of Products on Pathogenicity of Microorganisms.hPortions  of the stand- 
ard/zed suspensions,  based on 0.25 nil. per animal in the group, were centrifuged and the cells 
resuspended in the particular products under study to a total volume of 0.45 ml. per animal. 
Whert both SK and plasma (or serum or PG) were used the total volume of 0.45 mi. per animal 
consisted of 0.25 ml. of SK and 0.2 nil. of the blood product. When either substance was used 
individually, the total volume was made up to 0.45 liter with saline. Mice were infected intra- 
peritoneally with a dose of 0.45 ml. and observed for a 14 day period. 
Comparison of Human and Animal Plasma as Sources of Pla~minogen.--Preparadons of 
concentrated SK (varidase--10,000 units SK per ml.) were tltrated against human plasma. 
Although there was some variation in the end-point, depending upon the lot of SK and upon 
the particular plasma sample used, a dilution of SK ranging between 1:512 and 1:2048 still 
effected at least partial lysis. The relative insusceptibility of animal fibrin to streptococcal 
fibrinolysin has frequently been reported. The addition of a small amount of PG from human 
sources brought about rapid dissolution of these fibrin dots. One lot of PG was titrated and at 
a dilution of 1:16 (0.6 ml.) in combination with the broth culture of an SK-positive organism 
lysed rabbit plasma clots. Neither the broth culture nor PG individually lysed rabbit fibrin. 
Rabbit  plasma  clots were lysed without  the addition  of human  PG by employing highly 
concentrated SK (varidase). SK (10,000 units per ml.) through a dilution of 1:128 completely 
inhibited clot formation. At 1:512 SK was still able to bring about partial lysis of the rabbit 
clot. Results were essentially similar using mouse and hamster blood. 
EXPER  r~r~NTAL 
Effect of 3K, Human Plasma,  and Human PG on the Pathogenicity of SK- 
Positive Streptococd.-- 
Mice were divided into four groups and injected respectively with streptococcal suspen- 
sions in saline (controls), streptococci plus a combination of SK and human plasma or a com- 
bination of SK and PG, streptococci with plasma or PG alone, and streptococci plus SK alone. 
Numerous experiments were performed using the five strains of Group A and one of Group G 
streptococci. Results were essentially the same in most cases. 
The data presented in Table I and Fig. 1 indicate that streptococci suspended 
in both SK and plasma, or plasma alone, were markedly more pathogenic (as 
much as 60 per cent increase) for mice in terms of per cent mortality and mean 248  STREPTOKINASE-PLASMINOGEN  SYSTEm. I 
survival  days,  whereas  streptococcal suspensions  in  SK  were  not  similarly 
affected and occasionally showed a  slight decrease in deaths as compared to 
controls. Experiment 1, Table I is an exception in that SK alone also increased 
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FxG. 1.  Influence  of SK and human plasma on pathogenicity of SK-positive streptococci 
deaths. This effect was observed with the two strains of mice studied. When the 
streptococci were diluted 100 fold (Experiment 6), the effect of SK plus plasma, 
or plasma alone was insufficient to increase the mortality from the Type 25 
strain. SK, plasma, or a combination of these products produced no observable 
toxic manifestations when injected without microorganisms into mice. When 
human PG was substituted for plasma results were similar (Table II). In one 
experiment (Experiment 3) the SK-PG suspension caused more deaths (33 per R.  x.  m~s~-~R  AlW  G.  YOUNG  249 
cent) than the PG suspension. The latter did, however, increase pathogenicity 
of the streptococci (33 per cent) as compared to that of the organisms in saline. 
TABLE I 
Influence  of SK  and Human  Plasma  on Pathogenicity  of SK-Positive Streptococci 
No. of mice .................. 
Mortality, per cent ............ 
Mean survival time, days ...... 
No. of mice .................. 
Mortality, per cent ............ 
Mean survival time, days ...... 
No. of mice .................. 
Mortality, per cent ............ 
Mean survival time, days ...... 
No. of mice .................. 
Mortality, per cent ............ 
Mean survival time, days ...... 
No. of mice .................. 
Mortality, per cent ............ 
Mean survival time, days ...... 
No. of mice .................. 
Mortality, per cent ............ 
Mean survival time, days ...... 
No. of mice ................... 
Mortality, per cent ............. 
Mean survival time, days ....... 
1 
3 
2 
4 
[o. 
5 
6 
r§ 
Cells suspended  in 
Saline  I SK (1°'000) I  Phsma  I SK  (10'000)and  plasma 
~pe 4 streptococcus MP9* 
1~  i~  95 
3.2  1.0  1.1  1.6 
Type 4 streptococcus MP9 (I~ 
5.3  1.2  1.5  6.3 
Type 4 streptococ~s MP13  (1~ 
12  11  12  12 
33  91  ~  33 
2.0  2.2  1.0  4.0 
10 
80 
4.3 
10 
10 
10 
4.0 
Type 25 streptococcus 
100  90 
2.2  2.1 
Type 25 streptococcus  (10  ''1  )  f,o  I  80  100 
2.9  4.5 
Type 25 streptococcus  (10  -3  ) 
I  10  10 
0  20 
2.5 
10 
40 
7.0 
10 
20 
7.0 
10 
0 
12 
50 
3.2 
Streptococcus  No. 95 
12  12 
92  83 
2.9  2.3 
12 
58 
5.1 
* Indicates No. of mouse passages. 
:1: Dilution of standardized suspension. 
§ CF1 mice used--SMK mice in all other experiments. 
The concentrations of SK and PG were altered and tried in various combina- 
tions.  PG  was  concentrated  fourfold  (Table  II,  Experiment  2)  and  used  in 
combination with SK as before; the results were essentially the same as those 
obtained with the lower concentrations. A  1:4 dilution of PG in combination TABLE  II 
Influence oJ SK and Human PG on Pathogenicity of SK-Posltive Streptococci 
Experiment 
No. 
No. of mice, 
Mortality, per cent... 
Mean survival time, days. 
Cells suspended in 
Saline  I  SK  (I0'000)  land  PG  PG  I  SK  (I0'000) 
No. of mice. 
Mortality, per cent ..... 
Mean survival time, days. 
No. of mice .................. 
Mortality, per cent ............ 
Mean survival  time, days ...... 
No. of mice ..................  . 
MortaAity, per cent ............ 
Mean survival time, days ...... 
Type 4 streptococcus (10-  s)* 
1 
No. of mice ..................  . 
Mortality  , per cent ............ 
Mean survival time, days ...... 
12 
33 
2.2 
Saline 
12 
42 
2.6 
saline 
12  12 
67  75 
1.0  2.3 
SK (10,000)  PG 4X~  and PG 4X:~ 
12  12 
83  83 
1.0  1.2 
Streptococcus  No. 10 (10  -1's) 
12 
33 
4.0 
2 
12 
17 
3.5 
SK (1o,ooo) 
12 
17 
2.0 
s  clooool i 
PG  SK  (Io,oo0)  and  PG 
12  12  12 
83  50  8 
1.7  1.8  3.0 
Group G streptococcus  (10  "I) 
4  12 
$8 
2.8 
12  12 
1.2  .0 
SK (10,000)  PG 1:4  and  PG 1:4 
12  12 
92  50 
1.0  1.5 
Type 25 streptococcus (10  "I  ) 
SK (2500) 
and  PG 
12 
83 
4.6 
SK (2,coo) 
and  PG  1:2 
12 
83 
4.6 
12 
50 
2.5 
SK (io,ooo) 
12 
50 
2.5 
Saline 
5  12 
58 
2.8 
Saline 
No. of mice.  6  12 
~ortality, per cent.  67 
Nfean survival time, days..  3.0 
Saline 
7  ~o. of mice. 
~ortality, per cent. 
.~ean survival time, days... 
12 
67 
3.0 
PG  SE (2,50O) 
12  12 
92  42 
2.1  3.4 
PG  1:2  SK  (2,500) 
12  12 
83  42 
2.6  3.4 
* Dilution of standardized suspension. 
~; PG concentrated fourfold. 
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with SK increased the pathogenicity of the Group G  strain by 37 per cent as 
compared to the saline controls, whereas neither PG (1:4) nor SK individually 
had  an  effect  (Table II,  Experiment  5).  SK was  used  at  a  concentration  of 
2,500 units per ml.; PG was also used at a  1:2 dilution of its normal concentra- 
tion.  Such  variations  did  not  further  increase  or  decrease  mouse  mortality 
(Experiments 6  and 7). 
TABLE III 
Influence  of Human  Plasma,  Human Plasminogen,  and  Human  Serum  on Patkogenidty  of 
SK-Positive Streptococci 
No. of mice .................. 
Mortality, per cent ............ 
Mean survival time, days ...... 
No. of mice .................. 
Mortality, per cent ............ 
Mean survival time, days ...... 
No. of mice .................. 
Mortality, per cent ............ 
Mean survival time, days ...... 
No. of mice .................. 
Mortality, per cent ............. 
Mean survival time, days ....... 
No. of mice ................... 
Mortality, per cent ............. 
Mean survival time, days ....... 
Experiment 
No. 
1 
Cells suspended in 
Saline  Plasma  PG  Serum 
10 
78 
<1.0 
10 
78 
2.0 
46 
46 
2.3 
10 
20 
11.0 
10 
0 
Type 4 streptococcus (10  -i)* 
20  20  10 
100  90  80 
<1.0  <1.0  <1.0 
Type 4 streptococcus (10  -3) 
100 
<1.0 
Type 4 streptococcus (10-  3) 
10  10 
100  100 
1.2  <1.0 
46  22 
84  100 
2.0  1.9 
Type 28 streptococcus 
10  10  10 
70  80  70 
1.0  5.1  2.7 
Type 28 streptococcus (10  -1  ) 
10  10  10 
0  0  0 
* Dilution of standardized suspension. 
The Comparative Effect of Human  Plasma, Human PG, and Human Serum on 
the Patkogenicity  of Streptococci.--These  products, all from human  donors, in- 
creased mouse mortality from the two streptococcal strains studied to approxi- 
mately the same extent (Table HI). It was of interest to determine whether 
smaller amounts of plasma and PG would be effective. A  1:4 dilution of each 
was used. The diluted plasma resulted in an approximately 20 per cent increase 
in mortality, whereas  the undiluted plasma brought  about an approximately 
50 per cent increase as compared with that of saline controls. PG at a  dilution 
of 1:4 resulted in an increase in deaths of about 20 per cent in only two of five 252  STREPTOKINASE-PLASMINOGEN  SYSTEM. I 
experiments; undiluted PG usually increased deaths by 25 to 60 per cent, de- 
pending upon the strain used and the number of organisms inoculated. 
Effect  of Rabbit Plasma and Rabbit PG on  the Pathogenicity  of SK-Positive 
Streptococci.--It appeared of interest to determine whether plasma or PG from 
a species possessing a lower PG level than that of the human would influence 
mouse mortality to the same extent as does human plasma or human PG. Ac- 
cordingly, streptococci (Type 4) were suspended in rabbit plasma and in rabbit 
PG and the suspensions injected into mice. Results showed that rabbit plasma 
and rabbit PG increased mortality by 52 and 36 per cent respectively (Table 
IV). The rabbit  blood products thus increased mortality to about the same 
extent as human plasma and PG. 
TABLE  IV 
Influence of Rabbit Plasma and Rabbit PG on Pathogenicity of SK-Positive Streptococd 
No. of mice ..................... 
Mortality, per cent ............... 
Mean survival time, days ......... 
Saline 
36 
6 
3.5 
Cells suspended in 
Rabbit plasma  I  Rabbit PG 
Type 4 streptococcus (10-8)  * 
36 
58 
2.2 
24 
42 
2.1 
* Dilution of standardized suspension. 
Effect  of SK, Human Plasma, and Human PG on the Pathogenicity  of SK- 
Negative Group D Streptococci.--The ability of the SK-plasma system to alter 
the pathogenicity of a Group D streptococcal strain was studied in experiments 
utilizing several sources of human plasma and the results summarized in Table 
V. The data showed that cell suspensions in a  combination of SK and plasma 
caused higher mortality as evidenced by a  29 per cent increase in deaths as 
compared  to  saline  controls.  Plasma  suspensions  or  SK  suspensions  of  the 
microorganisms did not differ appreciably from saline suspensions.  Further- 
more, suspending the cells in plasma had no effect on their pathogenicity re- 
gardless  of whether the plasma was one which was  completely resistant to 
lysis or occasionally underwent partial or complete lysis when incubated over- 
night with this organism. One experiment (No. 2) was performed substituting 
PG for plasma. A combination of SK and PG increased deaths by 34 per cent, 
whereas either substance individually was without significant effect. 
Effect  of  SK  and  Human  Plasma  on  the  Pathogenicity  of  SK-Variable 
Salmonella  paratyphi.--Suspensions  of S.  paratyphi  in  SK-plasma increased 
deaths by as much as 58 per cent, whereas the same number of organisms sus- 
pended in either SK or plasma individually did not bring about a comparable 
increase over the mortality from saline suspensions (Table VI). In one experi- g.  t.  KRAS~rZR  A}~  O.  XOUSO  253 
TABLE  V 
Influence of SK, Human Plasma, and Human PG on Pathogenicity  of SK-Negatire Group D 
Streptococci 
No. of mice. 
Mortality, per cent. 
Mean  survival time, days .....  i 
Experi-  ment 
No. 
i  1  I 
Cells suspended in 
Saline I andSK  (10,000)plasma  Plasma  SK  (lO,OOO) 
Group D  streptococcus 
38 
24 
1.9 
Saline 
No. of mice.  2  12 
Mortality, per cent.  33 
Mean survival time, days.  < 1.0 
38  38 
53  29 
2.2  1.0 
S~0~(~)  PG 
12  12 
67  17 
<1.0  <1.0 
38 
18 
1.0 
SK (lO,OO0) 
12 
42 
<1.0 
TABLE  VI 
Influence o/SK and Human Plasma on Pathogenicity  of SK Variable Salmonella 
Experi- 
~I!  nt  Saline 
No. of mice ................  12 
Mortality, per cent  ...........  25 
Mean  survival time, days  ......  3  3 
]Saline[ 
Ceils suspended in 
SK (IO,OOO)  Plasma*  SK (10,000)  and plasma  (No. 617) 
S. paratyphi  (10-1)~ 
12  12  12 
67  42  33 
2.5  6.0  4.3 
SK (10,000)  Plasma§  SK (10,000)  and plasma  (No. 1455) 
No. of mice ................. 
Mortality, per cent ........... 
Mean survival time, days ..... 
No. of mice ................. 
Mortality, per cent ........... 
Mean survival time, days ..... 
19 
89 
1.1 
19 
5 
7.0 
S. paratyphi 
19  19 
100  42 
1.4  6.8 
S. paratyphi  (10  -l'~) 
19  19 
63  0 
4.6 
19 
74 
2.1 
19 
5 
13.0 
* Completely lysed by S. paratyphi overnight. 
:~ Dilution of standardized suspension. 
§ Not lysed by S. paratyphi overnight. 254  STREPTOKINASE-PLASMINOGEN SYSTEM. I 
ment plasma significantly decreased mouse mortality. Neither lysis-susceptible 
nor non-lysis-snsceptible plasma alone brought about an increase in virulence 
of S. paratyphi  (Table VI). Further evidence with three additional sources of 
human plasma, using 43 control mice and 43 test mice, also showed that plasma 
by itself has no effect on the pathogenicity of S. paratyphifor mice. 
TABLE VII 
Influence of SK and Human Plasma on Pathogenicity of SK-Negative Staphylococci 
No. of mice 
Mortality, per cent 
Mean survival time, days 
No. of mice 
Mortality, per cent 
Mean survival time, days 
No. of mice 
Mortality, per cent 
Mean survival time, days 
No. of mice 
Mortality, per cent 
Mean survival time, days 
Experiment 
No. 
1 (plasma 
No. 1) 
2 (plasma 
No. 1062) 
Saline 
10 
10 
14.0 
10 
10 
14.0 
3 (plasma  12 
No. 617)  8 
2.0 
4 (plasma  22 
No. 1456)  5 
2.0 
Cells suspended in 
SK (lo,ooo) 
and pbam~ 
I0 
60 
3.0 
I0 
50 
1.0 
Pl~ma 
10 
60 
2.7 
10 
56 
1.4 
12 
50 
3.6 
22 
67 
1.6 
sK (io,ooo) 
10 
20 
8.0 
I0 
20 
8.0 
k 
Effect  of SK,  Human Plasma,  and Human PG on the Pathogenicity  of SK- 
Negative  Staphylococci  for  Mice.--Two  experiments  were  performed  to  de- 
termine whether SK or plasma,  or a  combination of these substances would 
alter the virulence of the staphylococcal strain. In both cases the SK-plasma 
suspensions, or plasma alone (Nos.  1 and 1062), increased virulence by 40 to 
60 per cent as compared to saline controls (Table VII). The influence of plasma 
was  further  studied  in  three  experiments  utilizing  two  additional  plasma 
samples (Nos. 617 and 1456), and again, plasma caused a 40 to 60 per cent in- 
crease in  mouse mortality. The effect of plasma  alone on staphylococci re- 
quired further study since this organism is not a producer of SK. However, as 
previously noted, it was found to produce coagulase; it seemed probable that 
coagulase activator rather than PG was responsible for the increase in deaths. 
Accordingly, PG was prepared from serum 1456 and the experiment repeated 
with varying concentrations of SK and PG (Table VIII). Combinations of SK 
and PG at these concentrations increased the pathogenicity of staphylococci; R.  I.  KRA.SNER AND  G.  YOUNG  255 
neither of these substances  individually significantly  altered the number of 
resulting  deaths. 
TABLE VIII 
Effect of Varying  Concentrations of SK  and Human PG on  Pathogenicity of SK-Negative 
Staphylococci 
EXperiment 
No. 
~o. of mice  1 
.VIortality, per cent  PG No. 1456 
~ean survival time, days 
No. of mice  2 
~ortality, per cent  PG No. 1456 
~ean survival time, days 
No. of mice 
Mortality, per cent 
Mean survival time, days 
Saline 
22 
5 
8.0 
Saline 
12 
8 
8,0 
Saline 
3  12 
PG No. 1456  8 
2.0 
Cells suspended in 
SK (10,000) 
and PG 
22 
5O 
2.8 
SK (lo,ooo) 
and PG 1:4 
12 
33 
3.8 
SK  (20,000) 
and PG 3 X 
12 
73 
2.3 
PG  SK (10,000) 
22  22 
5  5 
6.0  14 
PG 1:4  SK  (10,000) 
12  12 
0  8 
14 
PG 3 X*  SK (20,000) 
12  12 
25  17 
5.3  6.5 
* PG concentrated threefold. 
DISCUSSION 
In the first series of experiments, using streptokinase-producing  streptococci, 
and human plasma as a source of plasmlnogen, an increase in mouse mortality 
was shown when the organisms were suspended in SK and plasma, or in plasma 
alone, but not, with one exception, with SK alone. Failure to obtain any in- 
crease in mortality from the SK suspensions might mean only that the or- 
ganisms  themselves  were producing  the maximal effective amount, in which 
case the added SK would represent an excess. On the other hand, there was 
nothing in these results to indicate that the active ingredient in the human 
plasma was plasminogen,  or that the streptoklnase-plasminogen  system was 
responsible for the change in pathogenicity. To narrow down the possibilities, 
a similar series was run, substituting a plasma fraction containing plasminogen 
for whole plasma.  The results were the same; in fact a comparative study of 
human plasma, plasminogen, and serum showed them to be uniformly effective 
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Rabbit plasma  and plasminogen produced  similar  results,  despite  the fact 
that the relative insusceptibility  of rabbit fibrin to lysis indicates a lower PG 
level  than  that of the human. It is, however,  possible that the activity of 
plasmin  in  lysing constituents of connective  tissue, rather than fibrinolysis, 
is a better index of its effect on disease production. This idea is supported by the 
recent reports  of Innerfield  (19, 20), Beiler and Martin  (21),  Day (22),and 
Hechter (23) on the ability of plasmin to increase tissue permeability. 
If, as now seemed likely, plasminogen was the effective substance in plasma, 
then plasma plus  streptokinase  might increase  the pathogenicity of an SK- 
negative organism, while plasma alone would be without effect. This proved to 
be the case when an SK-negative Group D streptococcus was used. The experi- 
ment was repeated with SK-variable strains of Salmonella paratyphi, and again 
the combination of SK and plasma increased mortality, while plasma alone was 
ineffective. Since in some cases the plasma used was lysed in vitro by the Salmo- 
nella, this uniform result seemed inconsistent with the results obtained with the 
streptococci. The rate of fibrinolysis by the Salmonella was, however, relatively 
slow as compared with that of the Group A and Group G streptococci. Results 
with the latter strains indicate that the SK-PG system exerts its greatest in- 
fluence on mouse mortality within the first 24 to 48 hours of infection.  (This 
was decidedly the case with dermal infections in rabbits which will be described 
in a later paper.)  It seems likely that insufficient fibrinolysin is produced  by 
the Salmonella in the early hours of infection to alter the course of the disease. 
Finally, the experiment  was run with SK-negative  staphylococci,  but with 
different results. Here plasma alone increased pathogenicity as effectively as in 
combination with streptokinase.  The effect was not due to plasminogen, how- 
ever; unlike the previous experiments with SK-positive streptococci, in which 
plasminogen gave the same results as whole plasma, in the case of the staphy- 
lococci plasminogen alone was usually ineffective, although still active in com- 
bination with SK. Since the staphylococci  were  coagulase-positive,  it seems 
likely that the whole plasma was also contributing coagulase activator, and 
that this was responsible for increasing virulence in the absence of SK. 
There seems no question but that the streptokinase-plasminogen  system does 
contribute to the pathogenicity of streptococci for mice, and is also capable of 
increasing mouse mortality with other organisms, including some which do not 
produce a fibrinolysin. Whether the mode of action is by breaking down a fibrin 
barrier, as has been generally assumed (24-29), or by increasing tissue permea- 
bility, as suggested by more recent studies (19-23), or by a combination of the 
two,  remains  to  be  shown. 
SUMMARY 
Human plasminogen,  plasma,  or serum  increased  the pathogenicity of six 
streptokinase-positive  streptococcal  strains for mice.  Combinations  of corn- R. I. KRASNER  AND  G. YOUNG  257 
mercia] streptokinase and plasminogen or streptokinase and plasma did not 
usually increase mouse mortality to a greater degree than did plasminogen or 
plasma alone, suggesting that the maximal effective amount of streptokinase 
was  produced by  the  organisms. 
The  pathogenicity of  Salmonella  paratyphi  (fibrinolysin variable)  and  a 
Group D streptococcus (streptokinase-negative) was not increased by plasmino- 
gen,  plasma,  or streptokinase,  whereas  a  combination of streptokiuase  and 
plasminogen,  or  streptokinase  and  plasma  did  significantly increase  mouse 
mortality resulting from these organisms. 
Combinations of certain  concentrations of streptokinase  and  plasminogen 
increased  the pathogenicity of  a  fibrinolysin-negative staphylococcal strain 
for mice to a greater extent than did either substance alone. 
The observed results provide evidence that streptokinase, by an interaction 
with plasminogen, contributes  to  the pathogenicity of streptokinase-positive 
streptococci. 
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